AI-generated summary
The authors studied HeLa cervical cancer cells in vitro, pre-treating them with protoporphyrin IX and then illuminating them with 635 nm laser light. They report significantly increased cytotoxic changes after 18 hours of pre-incubation and 48 hours after illumination, and suggest this timing could guide photodynamic therapy. The findings come from a laboratory cell study and do not establish clinical effectiveness.
- Who or what was studied
- HeLa cervical cancer cell line (in vitro cell culture)
- Wavelengths
- 635 nm
- Limits stated in the abstract
- This is an in vitro study on a single cell line, so results may not translate to human patients.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on pubmed.ncbi.nlm.nih.gov.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 635 nm
- Power density (irradiance)
- 30 mW/cm2
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photodynamic therapy, Laser, Low-level laser therapy. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.